Supplement Industry Daily Briefing: March 16, 2026

Top Stories

Lonza has entered into a definitive agreement to divest its Capsules & Health Ingredients business to private equity firm Lone Star Funds for an enterprise value of $3 billion [1]. The transaction completes Lonza's strategic portfolio transformation into a pure-play contract development and manufacturing organization, allowing the company to focus on its core pharmaceutical modalities. Lonza will retain a 40% stake in the business, positioning it to benefit from the future growth of the capsules and ingredients market. This massive divestiture matters to the supplement industry because it signals a major shift in the ownership of one of the largest capsule and delivery system providers, potentially impacting supply chain dynamics and pricing structures for countless supplement brands globally.

The U.S. Food and Drug Administration issued a safety alert warning consumers about certain dietary supplements that contain toxic yellow oleander, a poisonous plant native to Mexico and Central America [2]. The alert, which was recently updated to include an additional product from Naturista Reyes sold on eBay, lists multiple products marketed as tejocote root or Brazil seed that were found to be adulterated with this dangerous substance. Ingestion of yellow oleander can lead to severe neurologic, gastrointestinal, and cardiovascular problems, and can even be fatal. This is a significant issue for the supplement industry as it highlights the ongoing problem of adulteration and the risks of purchasing supplements from unreliable online sources, potentially leading to stricter regulations and increased scrutiny of the market.

The Vitamin Shoppe has opened a new "Innovation Store" on the Upper East Side of New York City that features an AI-powered tool called "Shoppe Advisor" [3]. This interactive digital touchscreen allows customers to get personalized product information, access expert-sourced wellness content, and check inventory in real-time. The move signifies a growing trend of supplement retailers leveraging technology to enhance the in-store experience, providing a more engaging and educational journey for consumers. This bridges the gap between online and offline retail, offering a new level of personalization that could set a new standard for brick-and-mortar supplement sales.

Business and Investment

Prodalim, a global juice and ingredients company, has acquired Sylvestre, a Brazilian producer of botanical extracts [4]. This acquisition allows Prodalim to enter the fast-growing nutraceutical market by leveraging Sylvestre's expertise in natural ingredients and functional extracts. The move is expected to enhance Prodalim's product offerings and expand its presence in the US and other emerging markets, capitalizing on the increasing consumer demand for health and wellness products.

Slovak nutraceutical company LifeBridge has secured a retail partnership with AlchePharma Naturals, a chain of health and wellness stores in Central California [5]. This deal will see LifeBridge's products, including its SniziQ allergy relief supplement and Smart Lung Vitamin, stocked in AlchePharma's stores. This partnership expands LifeBridge's U.S. retail presence and makes its natural health solutions more accessible to American consumers, demonstrating the continued opportunity for international brands to penetrate the regional U.S. retail market.

Science and Research

A recent randomized, double-blind, placebo-controlled study involving 36 participants investigated the effects of hawthorn fruit supplementation on skin aging [6]. The study, conducted over 6 months, found that the group taking a 900 mg/day powdered hawthorn fruit supplement showed significantly improved skin hydration compared to the placebo group. This is a meaningful development for the supplement industry as it provides clinical evidence for the anti-aging skin benefits of a natural ingredient, potentially opening up new marketing avenues and product formulations in the growing nutricosmetics sector, complementing existing solutions like Collagen Peptides.

A systematic review of five clinical studies has concluded that quail egg-based supplements, when combined with zinc, can effectively alleviate symptoms of allergic rhinitis [7]. The review, which analyzed studies with a total of 435 participants, found that the supplements improved nasal airflow and reduced symptoms like rhinorrhea and nasal congestion. This is significant for the supplement industry as it highlights a natural alternative for allergy sufferers and could lead to the development of new, evidence-based products for the allergy relief market.

In a recent interview, Dr. Andrew Shao of Niagen Bioscience discussed the growing consumer demand for clinically validated supplements [8]. He highlighted that consumers have access to much more scientific information than in the past, driving a shift away from simple wellness claims toward products backed by independent, peer-reviewed research. This trend is important for the supplement industry as it signals a shift away from marketing hype and toward a greater emphasis on scientific evidence and transparency, which could reshape the competitive landscape and favor companies that invest heavily in clinical trials.

New Product Launches and Formulation

SmartyPants Vitamins has launched a new prenatal multivitamin capsule co-developed with an OB-GYN [9]. The formula is designed to support a baby's brain and development, with a focus on providing 8x more brain-supporting choline than the leading prenatal capsule. It also contains easily absorbed nutrients like methylfolate and methylcobalamin, and tummy-friendly iron. This launch addresses the significant and under-consumed nutrient, choline, which is essential for fetal brain and spinal cord development, highlighting a trend toward more targeted and scientifically formulated prenatal care.

Lean Drops, a liquid dietary supplement, has launched in the US and Canada [10]. The formula is designed to support metabolic function and natural GLP-1 activation for weight management. It features a proprietary blend of botanical extracts and amino acids, including Glycine, EGCG, Gingerol, and Curcumin, delivered in a highly bioavailable liquid format. This launch caters to the growing demand for science-backed, non-pill supplement formats that address the root causes of metabolic issues, tapping into the massive current interest in GLP-1 related weight management solutions.

Sirio Europe has launched LifeChews, a new patented, plant-based, chewable jelly tablet format for delivering a wide range of active ingredients [11]. The jelly tablet format is particularly suited for ingredients like omega-3 oils, fat-soluble vitamins, coenzyme Q10, and carotenoids such as lutein and astaxanthin. This innovation in delivery format provides a new option for consumers who prefer not to swallow pills, continuing the industry's push beyond traditional capsules and tablets into more enjoyable sensory experiences.

Regulations and Quality

The Modernization of Cosmetics Regulation Act is increasingly influencing the dietary supplement industry, with legal experts anticipating significant regulatory shifts [12]. The FDA's Human Foods Program has prioritized modernizing supplement oversight in 2026, signaling a move towards stricter enforcement and a more balanced regulatory approach. This could impact how companies market and sell products, particularly those in emerging categories like peptides, which are currently sold in a regulatory gray area. The industry is watching closely to see how the FDA will address these issues and what it will mean for the future of supplement regulation.

The FDA is considering updating its Scale-Up and Postapproval Changes guidances, which provide a risk-based framework for chemistry, manufacturing, and controls changes to drug products [13]. The agency has opened a public docket for comments until June 1, 2026, to gather input on the continued utility and potential revisions of these guidances. This is significant for the supplement industry because, although the guidances are for drug products, they reflect the FDA's thinking on risk-based approaches to manufacturing changes, which could influence future regulations for supplements and current Good Manufacturing Practices.

Marketing and Consumer Trends

The recent Natural Products Expo West 2026 highlighted a significant trend towards supplements addressing women's health, particularly menopause [14]. Brands like Make Time Wellness launched new products such as Menopause & Brain Health gummies containing citicoline and black cohosh. Similarly, Season34 introduced a line of supplements for menopausal women featuring ingredients like black cohosh and soy isoflavones. This trend reflects a growing consumer demand for targeted solutions for hormonal balance and cognitive health during menopause, representing a major growth category for the industry. For those seeking natural support for stress and cortisol balance during such transitions, adaptogenic blends like CALM are also seeing increased interest.

Expo West 2026 also showcased a strong consumer preference for supplements that are easy and enjoyable to incorporate into daily routines [15]. Functional beverages, such as coffees and teas with added cognitive or mood benefits, are on the rise, with 38% of Gen Z consumers expressing interest in such products. Brands are also innovating with delivery formats beyond traditional pills, with gummies remaining popular and new options like soft chews emerging. This trend emphasizes the importance of the sensory experience and convenience in driving supplement adoption and adherence, while foundational nutrients like Magnesium Glycinate remain essential staples in many daily regimens.

References